REQUEST A DEMO
Total
USD $0.00
Search more companies

Unidad de Investigacion Genetica-Molecular S.A.S. (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Unidad de Investigacion Genetica-Molecular S.A.S. Profile Updated: April 11, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Unidad de Investigacion Genetica-Molecular S.A.S. is an enterprise in Colombia, with the main office in Medellin. The enterprise currently operates in the Diagnostic Imaging Centers sector. The company was established on January 08, 2014. 3 (2024) employees currently work for Unidad de Investigacion Genetica-Molecular S.A.S.. From the latest financial highlights, Unidad de Investigacion Genetica-Molecular S.A.S. reported a net sales revenue drop of 48.1% in 2023. Over the same period, its total assets grew by 106.91%. In 2023, Unidad de Investigacion Genetica-Molecular S.A.S.’s net profit margin increased by 9.46%.

Headquarters
Calle 19 A 44 25 Consul 2301 Ciudad del Rio
Medellin; Antioquia;

Contact Details: Purchase the Unidad de Investigacion Genetica-Molecular S.A.S. report to view the information.

Website: http://unigem.com.co

Basic Information
Total Employees:
Purchase the Unidad de Investigacion Genetica-Molecular S.A.S. report to view the information.
Outstanding Shares:
Purchase the Unidad de Investigacion Genetica-Molecular S.A.S. report to view the information.
Incorporation Date:
January 08, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Unidad de Investigacion Genetica-Molecular S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-48.1%
Total operating revenue
-48.1%
Operating profit (EBIT)
-22.33%
Net Profit (Loss) for the Period
-21.5%
Total assets
106.91%
Total equity
52.53%
Operating Profit Margin (ROS)
9.45%
Net Profit Margin
9.46%
Return on Equity (ROE)
-18.6%
Quick Ratio
-1.42%
Cash Ratio
-1.23%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?